1007-7669
2005 Issue 12
Clinical development and application of HIV entry inhibitors
ZHANG Hai-yan;JIANG He;CAI Shao-xi;XIE Dong
ZHANG Hai-yan;JIANG He;CAI Shao-xi;XIE Dong
..............page:977-981
Nesiritide: a new anti-heart failure drug
HUANG Zhen-hua
HUANG Zhen-hua
..............page:981-984
Influence of l-asparaginase on glycometabolism
JIANG Yue-lian;ZHANG Jian;LU Xiao-tong;SHEN Yong-nian
JIANG Yue-lian;ZHANG Jian;LU Xiao-tong;SHEN Yong-nian
..............page:985-987
Product brief of administrative protection of pharmaceuticals:other agents( 1 ) (continuation)
WANG Wei
WANG Wei
..............page:988-988
..............page:974-976
Pharmacological study and clinical application of meropenem
HUANG Zhong-yi
HUANG Zhong-yi
..............page:971-973
Effect of puerarin on cardiac cholinergic innervation ischemic area in rats after myocardial infarction
NI Xiu-qin;LI Xing;ZHAO Ling-hui;LIU Shi-wei;MA Jing;XU Jia-hui
NI Xiu-qin;LI Xing;ZHAO Ling-hui;LIU Shi-wei;MA Jing;XU Jia-hui
..............page:968-970
Clinical therapy of retinal vein occlusion with aescuven forte
GONG Yuan-yuan;YU Su-qin;WANG Hong;WANG Wei-jun;ZHU Ping;WU Xing-wei;XU Xun
GONG Yuan-yuan;YU Su-qin;WANG Hong;WANG Wei-jun;ZHU Ping;WU Xing-wei;XU Xun
..............page:965-968
Aescuven forte in treating central serous chorioretinopathy
WANG Wei-jun;GONG Yuan-yuan;WANG Hong;WU Ying;WU Xing-wei;XU Xun
WANG Wei-jun;GONG Yuan-yuan;WANG Hong;WU Ying;WU Xing-wei;XU Xun
..............page:961-964
Sodium oxybate alleviated brain injury of neonatal rats with hypoxic-ischemic insult
MA Zheng-liang;ZENG Yin-ming;XU Fu-tao;CHEN Ying;ZHANG Yan
MA Zheng-liang;ZENG Yin-ming;XU Fu-tao;CHEN Ying;ZHANG Yan
..............page:958-961
Determination of lovastatin concentration in human plasma by high performance liquid chromatography-electrospray mass spectrometry
YU Yun-qiu;HUANG Jian-ming;WENG Wei-yu;GU Li-hua;WANG Yi-jian;ZHANG Li
YU Yun-qiu;HUANG Jian-ming;WENG Wei-yu;GU Li-hua;WANG Yi-jian;ZHANG Li
..............page:954-957
Clinical effects of quetiapine vs perphenazine in treatment of elderly schizophrenia
WU Su-qin;CHEN Zhi-en;JI Lin-ying
WU Su-qin;CHEN Zhi-en;JI Lin-ying
..............page:951-954
Pharmacokinetics and bioequiavalence assessment of Ginkgo biloba extract dropping pills and tablets
WANG Chang-hong;LI Hong;CHOU Gui-xin;CHENG Xue-mei;ZHANG Fang;WANG Zheng-tao
WANG Chang-hong;LI Hong;CHOU Gui-xin;CHENG Xue-mei;ZHANG Fang;WANG Zheng-tao
..............page:946-950
Study on pharmacodynamics and permeation of oxaprozin gel in vitro
GUO Hong;LIU Zhi-dong;NIE Shu-fang;PAN Wei-san
GUO Hong;LIU Zhi-dong;NIE Shu-fang;PAN Wei-san
..............page:942-946
A clinical randomized controlled trial of pazufloxacin injection in treatment of bacterial infection in 111 patients
SHI Yi;XIAO Yong-ying;SU Xin;SHAO Hai-feng;SONG Yong;ZHAO Bei-lei;CAO E-hong;XIAO Xin-wu;WANG Wei-ping;XIAO Wei;WANG Mao-fen;SUN Li-hua;ZHANG Hui
SHI Yi;XIAO Yong-ying;SU Xin;SHAO Hai-feng;SONG Yong;ZHAO Bei-lei;CAO E-hong;XIAO Xin-wu;WANG Wei-ping;XIAO Wei;WANG Mao-fen;SUN Li-hua;ZHANG Hui
..............page:937-941
Protection of huperzine A against motor neuron injury in cultured rat spinal cord slice
LIU Wei-gang;XIAO Xiang-jian;LI Min;MA Zheng;LI Chun-yan
LIU Wei-gang;XIAO Xiang-jian;LI Min;MA Zheng;LI Chun-yan
..............page:933-937
Effects of peroxisome proliferator-activated receptor gamma on airway mucus production in a murine model of asthma
HUANG Hua-qiong;SHEN Hua-hao
HUANG Hua-qiong;SHEN Hua-hao
..............page:928-932
Determination of amodiaquine in human plasma by high performance liquid chromatography
ZHANG Jie;PEI Qi;LIU Shi-kun;ZHOU Yu-lu;ZHOU Chun-shan
ZHANG Jie;PEI Qi;LIU Shi-kun;ZHOU Yu-lu;ZHOU Chun-shan
..............page:925-928